Development of comprehensive disease assessment in systemic vasculitis
…, N Rasmussen, P Seo, K Westman… - Postgraduate …, 2008 - academic.oup.com
The systemic vasculitides are multisystem disorders with considerable mortality and morbidity
and frequent relapses. In the absence of reliable serological markers, accurate clinical …
and frequent relapses. In the absence of reliable serological markers, accurate clinical …
Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical …
…, DGI Scott, RA Watts, P Höglund, K Westman… - Annals of the …, 2011 - ard.bmj.com
… K Westman8, … Berden, S le Cessie (Leiden, The Netherlands); K de Groot (Offenbach,
Germany); A Ekstrand (… K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, …
Germany); A Ekstrand (… K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, …
[HTML][HTML] A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
Background The primary systemic vasculitides usually associated with autoantibodies to
neutrophil cytoplasmic antigens include Wegener's granulomatosis and microscopic polyangiitis…
neutrophil cytoplasmic antigens include Wegener's granulomatosis and microscopic polyangiitis…
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
…, M Segelmark, V Tesar, K Westman… - Annals of the …, 2016 - ard.bmj.com
In this article, the 2009 European League Against Rheumatism (EULAR) recommendations
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (…
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (…
EULAR recommendations for the management of primary small and medium vessel vasculitis
…, DGI Scott, C Stegeman, R Watts, K Westman… - Annals of the …, 2009 - ard.bmj.com
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of small and medium vessel vasculitis. Methods: An expert group (…
for the management of small and medium vessel vasculitis. Methods: An expert group (…
[HTML][HTML] Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis
…, D Walsh, M Walsh, K Westman… - … England Journal of …, 2010 - Mass Medical Soc
Background Cyclophosphamide induction regimens for antineutrophil cytoplasmic antibody
(ANCA)–associated vasculitis are effective in 70 to 90% of patients, but they are associated …
(ANCA)–associated vasculitis are effective in 70 to 90% of patients, but they are associated …
Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis
…, RA Sinico, CA Stegeman, KW Westman… - Journal of the …, 2007 - journals.lww.com
Systemic vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens (ANCA)
is the most frequent cause of rapidly progressive glomerulonephritis. Renal failure at …
is the most frequent cause of rapidly progressive glomerulonephritis. Renal failure at …
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis: a randomized trial
Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)–associated
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …
Long-term patient survival in ANCA-associated vasculitis
…, C Stegeman, M Walsh, K Westman… - Annals of the …, 2011 - ard.bmj.com
… Kerstin Westman6, … K/DOQI clinical practice guidelines for chronic kidney disease:
evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1–266. …
evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1–266. …
EULAR recommendations for the management of large vessel vasculitis
…, DGI Scott, C Stegeman, R Watts, K Westman… - Annals of the …, 2009 - ard.bmj.com
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of large vessel vasculitis. Methods: An expert group (10 rheumatologists…
for the management of large vessel vasculitis. Methods: An expert group (10 rheumatologists…